CIK: 0001910456 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value ($000): $117,385 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BELLUS HEALTH INC NEW | 2,831,588 | $26,164 | 22.3% | $7.70 | — | COM NEW | 07987C204 |
| — | MERUS N V | 1,001,217 | $22,668 | 19.3% | $30.23 | — | COM | N5749R100 |
| — | KINNATE BIOPHARMA INC | 1,674,677 | $21,118 | 18.0% | $12.05 | — | COM | 49705R105 |
| — | ALPINE IMMUNE SCIENCES INC | 1,926,869 | $16,398 | 14.0% | $12.06 | — | COM | 02083G100 |
| — | CYMABAY THERAPEUTICS INC | 2,589,679 | $7,640 | 6.5% | $3.16 | — | COM | 23257D103 |
| — | PARDES BIOSCIENCES INC | 2,180,560 | $6,694 | 5.7% | $7.88 | — | COM | 69945Q105 |
| — | PIERIS PHARMACEUTICALS INC | 3,223,334 | $6,028 | 5.1% | $2.37 | — | COM | 720795103 |
| IMUX | IMMUNIC INC | 1,104,241 | $3,832 | 3.3% | $6.41 | 0.0% | COM | 4525EP101 |
| — | AEROVATE THERAPEUTICS INC | 191,565 | $2,994 | 2.6% | $16.58 | — | COM | 008064107 |
| — | THESEUS PHARMACEUTICALS INC | 504,862 | $2,792 | 2.4% | $10.58 | — | COM | 88369M101 |
| — | PASSAGE BIO INC | 421,410 | $995 | 0.8% | $2.55 | — | COM | 702712100 |
| — | OTONOMY INC | 30,000 | $62 | 0.1% | $2.07 | — | COM | 68906L105 |